Cigna Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
19,319
-201
-1% -$11.5K 0.14% 118
2026
Q1
$1.18M Hold
19,520
0.18% 101
2025
Q4
$1.05M Sell
19,520
-485
-2% -$23.3K 0.15% 120
2025
Q3
$902K Hold
20,005
0.13% 143
2025
Q2
$926K Sell
20,005
-378
-2% -$18.6K 0.16% 134
2025
Q1
$1.24M Sell
20,383
-398
-2% -$23.2K 0.23% 91
2024
Q4
$1.18M Sell
20,781
-125
-0.6% -$6.98K 0.21% 96
2024
Q3
$1.08M Sell
20,906
-461
-2% -$21.6K 0.19% 108
2024
Q2
$888K Sell
21,367
-145
-0.7% -$6.49K 0.16% 124
2024
Q1
$1.17M Sell
21,512
-269
-1% -$13.7K 0.22% 96
2023
Q4
$1.12M Sell
21,781
-683
-3% -$35.9K 0.23% 94
2023
Q3
$1.3M Sell
22,464
-3,047
-12% -$187K 0.3% 64
2023
Q2
$1.63M Sell
25,511
-355
-1% -$23.8K 0.3% 58
2023
Q1
$1.79M Sell
25,866
-513
-2% -$36.2K 0.36% 53
2022
Q4
$1.9M Buy
26,379
+141
+0.5% +$10.6K 0.39% 48
2022
Q3
$1.87M Sell
26,238
-1,457
-5% -$106K 0.41% 45
2022
Q2
$2.13M Sell
27,695
-11,451
-29% -$872K 0.42% 46
2022
Q1
$2.86M Sell
39,146
-11,462
-23% -$770K 0.35% 58
2021
Q4
$3.16M Sell
50,608
-17,651
-26% -$1.04M 0.25% 68
2021
Q3
$4.04M Sell
68,259
-1,546
-2% -$102K 0.3% 64
2021
Q2
$4.67M Sell
69,805
-11,020
-14% -$719K 0.33% 58
2021
Q1
$5.1M Buy
80,825
+1,712
+2% +$107K 0.35% 61
2020
Q4
$4.91M Buy
79,113
+6,013
+8% +$370K 0.38% 53
2020
Q3
$4.41M Sell
73,100
-3,446
-5% -$207K 0.42% 48
2020
Q2
$4.5M Buy
76,546
+10,164
+15% +$608K 0.43% 47
2020
Q1
$3.7M Buy
66,382
+1,077
+2% +$65.8K 0.48% 41
2019
Q4
$4.11M Buy
65,305
+17,288
+36% +$990K 0.43% 42
2019
Q3
$2.75M Buy
48,017
+2,417
+5% +$114K 0.28% 75
2019
Q2
$2.02M Sell
45,600
-1,500
-3% -$69.9K 0.22% 97
2019
Q1
$2.25M Sell
47,100
-3,331
-7% -$166K 0.25% 79
2018
Q4
$2.62M Buy
50,431
+1,124
+2% +$60.4K 0.22% 63
2018
Q3
$2.49M Sell
49,307
-16,088
-25% -$955K 0.2% 75
2018
Q2
$3.62M Sell
65,395
-7,963
-11% -$430K 0.26% 54
2018
Q1
$4.64M Sell
73,358
-712
-1% -$45.8K 0.31% 44
2017
Q4
$4.54M Sell
74,070
-2,628
-3% -$164K 0.3% 46
2017
Q3
$4.89M Sell
76,698
-1,170
-2% -$68.3K 0.33% 40
2017
Q2
$4.34M Buy
77,868
+9,200
+13% +$501K 0.3% 46
2017
Q1
$3.73M Buy
68,668
+7,051
+11% +$387K 0.26% 51
2016
Q4
$3.6M Buy
+61,617
New +$3.37M 0.39% 48

Other funds holding BMY

Cigna Investments's BMY Position: Q2 2026 in Review

Cigna Investments reduced its Bristol-Myers Squibb (BMY) stake by 1% in Q2 2026, selling an estimated $11.5K and leaving 19,319 shares worth $1.11M. The position accounts for 0.14% of the portfolio, ranked #118.

Cigna Investments first reported a position in BMY in Q4 2016 and has held it in 39 quarters since. The position peaked at $5.1M in Q1 2021. 891 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cigna Investments held 19,319 shares of Bristol-Myers Squibb worth $1.11M as of Q2 2026.
  • Cigna Investments sold 201 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
  • Bristol-Myers Squibb made up 0.14% of Cigna Investments's portfolio in Q2 2026, its #118 holding.
  • Cigna Investments first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 39 quarters since.
  • Cigna Investments's Bristol-Myers Squibb position peaked at $5.1M in Q1 2021.
  • 891 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.